bpc-157 fda approval status warning FDA's Overreach on Compounded Peptides fda bpc-157 not approved peptide

They also support research on biochemical regulation

Populations who should not use BPC-157: Pregnant or breastfeeding individuals (no safety data), anyone with a history of cancer (theoretical concern given pro-angiogenic mechanisms), individuals taking anticoagulants (some animal data suggest effects on platelet aggregation pathways), and anyone without access to sterile technique for injection preparation

Theoretical Cancer Risk (Tumor Growth): A major dark side of BPC-157s healing mechanisms is the possibility that it could unintentionally stimulate cancerous growth

This means that every time you think you are using 1mg of Tirzepatide, you are only using 0.5mg, which can throw off your entire experiment

At 10mg/ml (1ml water added): Draw 75 units